About ERN LUNG
Expertise
patients
clinicians
ERN-LUNG Academy

The ERN-LUNG Academy is a curriculum for medical staff at any stage of their career, who wishes to get a proof of knowledge on rare respiratory diseases. It consists of Webinars and eCases, but also includes on-site training in ERN-LUNG Centers. We call for applications from participants of EU-member States from September to November each year. Classes start in January. If you wish to apply for next yearโ€™s class, please send a letter of motivation to info@ern-lung.eu

ERN-LUNG Online advance system

The EXpert Advisory BOard (EXABO) is a pan-European internet platform, which has been developed in the context of ERN-LUNG in liaison with the Medical Informatics Group of University Hospital Frankfurt, to answer questions on all aspects of rare respiratory diseases. The platform is primarily aimed at patients and care team members but is openly accessible by anyone who wants to ask a related question.

NETWORK
News

ERNs special issue on OJRD – Call for contributions

ERN-Lung Logo Transparent

European Reference Networks (ERNs) connect 1,606 expert centers across Europe to harmonize care for rare and complex diseases through multidisciplinary collaboration and shared clinical guidelines. By utilizing the European Commissionโ€™s secure Clinical Patient Management System 2.0, specialists have virtually consulted on over 4,900 difficult cases, eliminating the need for patient travel. These networks have proven their resilience during global crises and maintained high quality standards, with a 2023 evaluation confirming that 95% of members meet rigorous benchmarks. Currently, the JARDIN Joint Action is working to integrate these mature networks into national healthcare systems to ensure sustainable, equitable access to specialized expertise for all patients.

The Orphanet Journal for Rare Diseases recently released a definitive paper on European Reference Networks. Written by leadership from all 24 networks, the publication highlights how ERNs are revolutionizing rare disease management by facilitating the cross-border exchange of medical expertise, ensuring patients receive top-tier care without having to leave their home countries.
Read the full article here